As Neurocrine Biosciences (NBIX) Market Valuation Rose, Shareholder Bb Biotech Ag Lowered Its Holding; Ppg Industries (PPG) Shareholder Cypress Capital Management Has Lowered Its Holding as Stock Declined

August 12, 2018 - By Jason Dias

PPG Industries, Inc. (NYSE:PPG) Logo

Bb Biotech Ag decreased its stake in Neurocrine Biosciences Inc. (NBIX) by 1.45% based on its latest 2018Q1 regulatory filing with the SEC. Bb Biotech Ag sold 50,000 shares as the company’s stock rose 12.53% while stock markets declined. The institutional investor held 3.40M shares of the health care company at the end of 2018Q1, valued at $282.19M, down from 3.45 million at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Neurocrine Biosciences Inc. for a number of months, seems to be less bullish one the $10.72 billion market cap company. The stock decreased 0.75% or $0.9 during the last trading session, reaching $118.46. About 448,731 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 93.65% since August 12, 2017 and is uptrending. It has outperformed by 81.08% the S&P500. Some Historical NBIX News: 10/04/2018 – AbbVie Remains Confident in NDA and Continues to Work With FDA to Bring Elagolix to Patients; 30/04/2018 – NEUROCRINE BIO 1Q REV. $71.1M, EST. $65.4M; 13/03/2018 – ABBVIE ELAGOLIX STUDY MET PRIMARY ENDPOINT; 30/04/2018 – Neurocrine 1Q Loss $41.8M; 30/04/2018 – Neurocrine 1Q Rev $71.1M; 08/05/2018 – NEUROCRINE PRESENTS NEW QUALITY OF LIFE DATA FROM RE-KINECT; 25/04/2018 – NEUROCRINE SAYS INGREZZA IMPROVES TARDIVE DYSKINESIA SYMPTOMS; 19/04/2018 – Neurocrine Bio Presenting at Conference Apr 25; 10/04/2018 – AbbVie: Regulatory Submissions for Elagolix in Uterine Fibroids Remain on Track; 16/03/2018 – $NBIX has raised the price of Ingrezza 40mg capsule by 9% effective 3/15/18, meanwhile $TEVA Austedo has surpassed on TRx. [h/t Cowen & ISI]

Cypress Capital Management Llc decreased its stake in Ppg Industries Inc (PPG) by 67.49% based on its latest 2018Q1 regulatory filing with the SEC. Cypress Capital Management Llc sold 3,750 shares as the company’s stock declined 12.02% with the market. The institutional investor held 1,806 shares of the basic industries company at the end of 2018Q1, valued at $202,000, down from 5,556 at the end of the previous reported quarter. Cypress Capital Management Llc who had been investing in Ppg Industries Inc for a number of months, seems to be less bullish one the $26.01B market cap company. The stock decreased 2.86% or $3.11 during the last trading session, reaching $105.77. About 2.37 million shares traded or 36.30% up from the average. PPG Industries, Inc. (NYSE:PPG) has declined 3.28% since August 12, 2017 and is downtrending. It has underperformed by 15.85% the S&P500. Some Historical PPG News: 10/05/2018 – PPG: CO. HAS IDENTIFIED SOME INADVERTENT ERRORS; 27/03/2018 – AKZO NOBEL CEO VANLANCKER: COMPANY WILL RETURN 7.5 BLN EUROS TO SHAREHOLDERS AFTER CHEMICALS DIVISION SALE; 10/05/2018 – PPG Industries: Former Vice Pres and Controller Was Put on Administrative Leave as of April 25, 2018; 10/05/2018 – PPG Industries: Errors Will Be Corrected as Appropriate; 19/04/2018 – PPG Industries: Commitment Remains to Deploy at Least $2.4 Billion on Acquisitions and Buybacks in 2018; 17/04/2018 – PPG Industries Closes Above 200-Day Moving Average: Technicals; 09/05/2018 – PPG Recognized as CIO 100 Award Winner for Fourth Time; 19/04/2018 – PPG Industries 1Q Effective Tax Rate 23.5%; 27/04/2018 – PPG Industries Sees Other Cash Costs of $35M-$40M; 16/04/2018 – PPG Industries Inc expected to post earnings of $1.40 a share – Earnings Preview

Bb Biotech Ag, which manages about $3.62 billion US Long portfolio, upped its stake in Tesaro Inc. (NASDAQ:TSRO) by 583,550 shares to 1.63M shares, valued at $93.12M in 2018Q1, according to the filing. It also increased its holding in Esperion Therapeutics Inc. (NASDAQ:ESPR) by 50,000 shares in the quarter, for a total of 2.41M shares, and has risen its stake in Radius Health Inc. (NASDAQ:RDUS).

Since February 9, 2018, it had 0 insider purchases, and 11 sales for $34.95 million activity. The insider LYONS GARY A sold 5,000 shares worth $423,341. Grigoriadis Dimitri E. had sold 86,963 shares worth $8.65M. Nevinny Corinne H sold 5,000 shares worth $415,625. Shares for $1.20 million were sold by BENEVICH ERIC. 126,832 shares valued at $10.24 million were sold by GORMAN KEVIN CHARLES on Tuesday, May 1. Another trade for 1,979 shares valued at $175,090 was made by Lippoldt Darin on Monday, March 5.

Among 14 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 61 analyst reports since August 18, 2015 according to SRatingsIntel. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) earned “Outperform” rating by Oppenheimer on Friday, January 27. On Tuesday, May 1 the stock rating was maintained by JP Morgan with “Overweight”. The rating was upgraded by Jefferies on Tuesday, October 3 to “Buy”. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has “Buy” rating given on Thursday, November 2 by H.C. Wainwright. Robert W. Baird maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Thursday, September 21 with “Buy” rating. Needham maintained it with “Buy” rating and $58.0 target in Friday, September 15 report. Cowen & Co maintained the stock with “Buy” rating in Friday, March 16 report. As per Tuesday, October 18, the company rating was initiated by Needham. On Wednesday, July 25 the stock rating was maintained by Robert W. Baird with “Outperform”. Piper Jaffray maintained the shares of NBIX in report on Thursday, October 8 with “Overweight” rating.

Analysts await Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to report earnings on November, 7. They expect $0.42 earnings per share, up 423.08% or $0.55 from last year’s $-0.13 per share. NBIX’s profit will be $38.00M for 70.51 P/E if the $0.42 EPS becomes a reality. After $-0.07 actual earnings per share reported by Neurocrine Biosciences, Inc. for the previous quarter, Wall Street now forecasts -700.00% EPS growth.

Investors sentiment decreased to 1.16 in 2018 Q1. Its down 0.15, from 1.31 in 2017Q4. It turned negative, as 22 investors sold NBIX shares while 79 reduced holdings. 36 funds opened positions while 81 raised stakes. 89.67 million shares or 1.73% less from 91.25 million shares in 2017Q4 were reported. Morgan Stanley has invested 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 38,413 are held by Barclays Plc. Manufacturers Life Ins The has 0% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Bnp Paribas Asset Sa, France-based fund reported 109,746 shares. Texas-based Teacher Retirement System Of Texas has invested 0.01% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Ameriprise Financial stated it has 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 5,157 shares. Raymond James And Associates holds 0% or 9,284 shares in its portfolio. The New York-based Orbimed Advisors Ltd Liability Com has invested 0.08% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Eventide Asset Management Limited Company owns 156,000 shares or 0.61% of their US portfolio. Crow Point Prns Ltd Liability has 2,728 shares. 4,900 are owned by Bailard Inc. Btg Pactual Global Asset Mgmt, Bermuda-based fund reported 11,865 shares. Moreover, Mirae Asset Glob Invs Co Limited has 0.09% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 80,292 shares. Dafna Cap Mngmt Lc reported 54,508 shares stake.

More notable recent Neurocrine Biosciences, Inc. (NASDAQ:NBIX) news were published by: Benzinga.com which released: “4 Reasons Behind Stifel’s Neurocrine Bull Thesis” on August 07, 2018, also 247Wallst.com with their article: “Jefferies Has 4 Top Biotech and Video Gaming Stocks to Buy Now” published on August 08, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on August 07, 2018. More interesting news about Neurocrine Biosciences, Inc. (NASDAQ:NBIX) were released by: Streetinsider.com and their article: “AbbVie (ABBV), Neurocrine Biosciences, Inc. (NBIX) Secure FDA Approval of ORILISSA (elagolix)” published on July 24, 2018 as well as Livetradingnews.com‘s news article titled: “The Street’s Key Stock Analysts Research Reports” with publication date: August 08, 2018.

Analysts await PPG Industries, Inc. (NYSE:PPG) to report earnings on October, 18. They expect $1.59 earnings per share, up 4.61% or $0.07 from last year’s $1.52 per share. PPG’s profit will be $391.00M for 16.63 P/E if the $1.59 EPS becomes a reality. After $1.90 actual earnings per share reported by PPG Industries, Inc. for the previous quarter, Wall Street now forecasts -16.32% negative EPS growth.

Since February 22, 2018, it had 0 insider buys, and 1 insider sale for $1.10 million activity.

Cypress Capital Management Llc, which manages about $611.62M and $518.09 million US Long portfolio, upped its stake in Jp Morgan Chase & Company (NYSE:JPM) by 3,931 shares to 130,686 shares, valued at $14.37M in 2018Q1, according to the filing. It also increased its holding in Pnc Financial Services Group (NYSE:PNC) by 2,129 shares in the quarter, for a total of 78,283 shares, and has risen its stake in Berkshire Hathaway Inc (BRKB).

Investors sentiment decreased to 0.98 in 2018 Q1. Its down 0.02, from 1 in 2017Q4. It fall, as 42 investors sold PPG shares while 246 reduced holdings. 66 funds opened positions while 215 raised stakes. 183.14 million shares or 1.72% less from 186.33 million shares in 2017Q4 were reported. Gamble Jones Investment Counsel reported 3,060 shares or 0.03% of all its holdings. Carderock Capital Management has 0.68% invested in PPG Industries, Inc. (NYSE:PPG) for 13,784 shares. Cornerstone Advsr Incorporated has 2,122 shares for 0.16% of their portfolio. Colonial Tru Advisors stated it has 21,262 shares or 0.48% of all its holdings. Philadelphia Trust Co holds 0.2% or 21,350 shares. Acadian Asset Mngmt Limited Liability Corporation reported 0% of its portfolio in PPG Industries, Inc. (NYSE:PPG). Ing Groep Nv holds 0.02% of its portfolio in PPG Industries, Inc. (NYSE:PPG) for 10,722 shares. Cape Cod Five Cents Retail Bank has 0.05% invested in PPG Industries, Inc. (NYSE:PPG) for 2,844 shares. Foster And Motley Incorporated, a Ohio-based fund reported 8,451 shares. Baystate Wealth Limited Co reported 1,040 shares stake. Novare Cap Ltd Com, North Carolina-based fund reported 49,268 shares. Smith Asset Mgmt Gp Limited Partnership accumulated 68,871 shares or 0.25% of the stock. Fmr Ltd Limited Liability Company has 428,034 shares for 0.01% of their portfolio. Pennsylvania Tru reported 15,397 shares. First Personal Services invested 0.04% in PPG Industries, Inc. (NYSE:PPG).

Among 26 analysts covering PPG Industries (NYSE:PPG), 14 have Buy rating, 0 Sell and 12 Hold. Therefore 54% are positive. PPG Industries had 87 analyst reports since September 6, 2015 according to SRatingsIntel. On Monday, August 7 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Hold” rating on Friday, January 19 by SunTrust. On Tuesday, March 22 the stock rating was reinitiated by Credit Suisse with “Outperform”. Citigroup maintained it with “Neutral” rating and $123 target in Tuesday, April 24 report. Seaport Global maintained the shares of PPG in report on Tuesday, January 23 with “Buy” rating. Susquehanna maintained PPG Industries, Inc. (NYSE:PPG) on Monday, January 8 with “Hold” rating. The stock has “Buy” rating by Jefferies on Tuesday, October 17. On Friday, October 16 the stock rating was upgraded by UBS to “Buy”. The rating was upgraded by Goldman Sachs on Wednesday, July 25 to “Buy”. The stock of PPG Industries, Inc. (NYSE:PPG) earned “Neutral” rating by Citigroup on Wednesday, January 24.

PPG Industries, Inc. (NYSE:PPG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts